C. Charles-Schoeman, R. Fleischmann, J. Davignon
Feb 25, 2015
Citations
6
Influential Citations
165
Citations
Quality indicators
Journal
Arthritis & Rheumatology (Hoboken, N.j.)
Abstract
Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis (RA). Systemic inflammation is proposed to play a fundamental role in the altered lipid metabolism associated with RA; however, the underlying mechanisms are unknown. We undertook this study to compare cholesterol and lipoprotein kinetics in patients with active RA with those in matched healthy volunteers.